The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Leveraging Commercial Data Infrastructure in Clinical Drug Development is the greatest connectivity we can have in the ...

Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from ...